dextromethorphan dxm cough suppressant overthecounter cold cough medicines affects nmda receptors brain implicated pathophysiology depression fda approved formulation combined bupropion named auvelity serve rapid acting antidepressant patients major depressive disorder morphinan class medications sedative dissociative stimulant properties lower doses dextromethorphan significant affinity muopioid receptor activity typical morphinan compounds exerts therapeutic effects several pure form dextromethorphan occurs white exceeding approved dosages dextromethorphan acts dissociative hallucinogen multiple mechanisms action including actions nonselective serotonin reuptake receptor dextromethorphan major metabolite dextrorphan also block nmda receptor high doses produces effects similar dissociative anesthetics ketamine nitrous oxide phencyclidine patented approved medical use primary use dextromethorphan cough suppressant temporary relief cough caused minor throat bronchial irritation commonly accompanies flu common cold inhaled particle irritants well chronic cough higher dextromethorphan available alone form cough syrup pills well combination agents fda approved combination drug dextromethorphanquinidine brand name treatment pseudobulbar affect uncontrollable laughingcrying dextromethorphan actual therapeutic agent combination quinidine merely serves inhibit enzymatic degradation dextromethorphan thereby increase circulating concentrations via inhibition combination medicine dextromethorphanbupropion approved major depressive disorder brand name dextromethorphan trigger histamine release allergic reaction atopic children especially susceptible allergic reactions administered dextromethorphan absolutely necessary strict supervision healthcare side effects dextromethorphan normal therapeutic doses rare side effect respiratory dextromethorphan thought cause olneys lesions administered intravenously however later proven inconclusive due lack research humans tests performed rats giving mg every day long month neurotoxic changes including vacuolation observed posterior cingulate retrosplenial cortices rats administered nmda receptor antagonists pcp many documented casescitation needed dextromethorphan produced psychological dependence people used recreationally considered less addictive common cough suppressants weak opiate since dextromethorphan also acts serotonin reuptake inhibitor users report regular recreational use long period time cause withdrawal symptoms similar antidepressant discontinuation syndrome additionally disturbances reported sleep senses movement mood thinking adverse effects dextromethorphan overdose doses times recommended therapeutic verification doses times recommended therapeutic episodic acute psychosis occur high doses dextromethorphan taken recreational use abundance psychiatric symptoms result including dissociation pcplike serotonin syndrome may result combined use dextromethorphan serotonergic antidepressants selective serotonin reuptake inhibitor ssris monoamine oxidase inhibitor research needed determine whether doses dextromethorphan beyond normally used therapeutically needed produce case dextromethorphan taken maois due possibility serotonin syndrome potentially lifethreatening condition occur rapidly due buildup excessive amount serotonin body patients taking dextromethorphan exercise caution drinking grapefruit juice eating grapefruit compounds grapefruit affect number drugs including dextromethorphan inhibition cytochrome system liver lead excessive accumulation drug increases prolongs effects grapefruit grapefruit juices especially white grapefruit juice also including citrus fruits bergamot lime well number noncitrus generally recommended avoided using dextromethorphan numerous medications dextromethorphan found possess following actions Î¼m using rat dextromethorphan prodrug dextrorphan actual mediator dissociative effects acting potent nmda receptor antagonist dextromethorphan role dextromethorphans major metabolite plays effects entirely following oral administration dextromethorphan rapidly absorbed gastrointestinal tract enters bloodstream crosses barriercitation needed therapeutic doses dextromethorphan acts centrally meaning acts brain opposed locally respiratory tract elevates threshold coughing without inhibiting ciliary activity dextromethorphan rapidly absorbed gastrointestinal tract converted active metabolite dextrorphan liver cytochrome enzyme average dose necessary effective antitussive therapy mg depending individual international society study cough recommends adequate first dose medication mg adult repeat dosing infrequent rather qds dextromethorphan elimination halflife approximately hours individuals extensive metabolizer phenotype increased approximately hours dextromethorphan given combination duration action oral administration three eight hours dextromethorphan hydrobromide hours dextromethorphan polistirexcitation needed around one caucasian population little enzyme activity leading longlived high drug first pass hepatic portal vein results drug metabolized odemethylation active metabolite dextromethorphan called dextrorphan derivative dextromethorphan therapeutic activity dextromethorphan believed caused drug metabolite dextromethorphan also undergoes ndemethylation partial conjugation glucuronic acid sulfate ions hours dextromethorphan therapy humans metabolites traces unchanged drug detectable major metabolic catalyst involved cytochrome enzyme known significant portion population functional deficiency enzyme known poor metabolizers odemethylation dextromethorphan dextrorphan contributes least dextrorphan formed dextromethorphan major metabolic pathway inactivation dextromethorphan duration action effects dextromethorphan increased much three times poor one study americans found fast extensive metabolizers intermediate metabolizers slow metabolizers number alleles known including several completely inactive variants distribution alleles uneven amongst ethnic groups large number medications potent inhibitors types medications known inhibit include certain ssris tricyclic antidepressants antipsychotics commonly available antihistamine diphenhydramine therefore potential interactions exists dextromethorphan medications inhibit enzyme particularly slow metabolizers dextromethorphan also metabolized ndemethylation primarily accomplished contributing least mem formed primary metabolite number cyp enzymes implicated minor pathways dextromethorphan metabolism effective ndemethylation dextromethorphan since average individual much lower content liver compared ndemethylation dextromethorphan catalyzed dextromethorphan dextrorotatory enantiomer levomethorphan methyl ether levorphanol opioid analgesics named according iupac rules pure form dextromethorphan occurs odorless opalescent white powder freely soluble chloroform insoluble water hydrobromide salt watersoluble ml dextromethorphan commonly available monohydrated hydrobromide salt however newer extendedrelease formulations contain dextromethorphan bound ionexchange resin based polystyrene sulfonic acid dextromethorphans specific rotation water sodium dlinecitation needed several routes exist synthesis dextromethorphan even though many syntheses known since middle century researchers still working today develop synthesis dextromethorphan example make environmentally friendly includes synthesis means ionic liquidscitation needed since one stereoisomers desired effect separation racemic mixture hydroxy n methyl morphinan using tartaric acid subsequent methylation hydroxyl group suitable method using dtartrate isomer remains product synthetic pathway patented roche traditional synthetic route uses raney nickel improved time example use ibuprofen overall costeffective method moderate reaction conditions easy handle suitable industrial productioncitation needed grewes cyclization easier handle terms chemicals used produces higher yields higher purity formylation prior cyclization avoids ether cleavage side reaction yields higher without nsubstitution nmethylation example purification done formation brucine saltcitation needed process also patented roche racemic parent compound racemorphan first described swiss us patent application hoffmannla roche respectively patent granted resolution two isomers racemorphan tartaric acid published dextromethorphan successfully tested part us navy ciafunded research nonaddictive substitutes dextromethorphan approved fda overthecounter initially hoped dextromethorphan solution problems associated use codeine phosphate cough suppressant sedation opiate dependence like dissociative anesthetics phencyclidine ketamine dextromethorphan later became associated nonmedical dextromethorphan became available overthecounter tablet form brand name romilar romilar taken shelves burst sales frequent misuse years later products unpleasant taste introduced robitussin dextrotussion later manufacturers began producing products better advent widespread internet access allowed users rapidly disseminate information dextromethorphan online discussion groups formed around use acquisition drug early dextromethorphan hydrobromide powder could purchased bulk online retailers allowing users avoid consuming dextromethorphan syrup fda panels considered moving dextromethorphan prescription status due potential abuse voted recommendation september citing lack evidence making prescriptiononly would curb states restricted sale dextromethorphan adults put restrictions purchase place similar pseudoephedrine january dextromethorphan prohibited sale minors state california state oregon january except doctors several states also begun regulating sales dextromethorphan minors indonesia national agency drug food control bpomri prohibited singlecomponent dextromethorphan drug sales without prescription indonesia country world makes singlecomponent dextromethorphan illegal even violators may prosecuted law national antinarcotics agency bnn ri even threatened revoke pharmacies drug stores licenses still stock dextromethorphan notify police criminal result regulation medications withdrawn market containing multicomponent dextromethorphan still sold may used generic labels store brands benylin dm mucinex dm tablets robitussin nyquil dimetapp vicks coricidin delsym theraflu charcoal cinfatÃ³s others used counterfeit medicationscitation needed overthecounter preparations containing dextromethorphan used manners inconsistent labeling often recreational doses much higher medically recommended dextromethorphan major metabolite dextrorphan acts nmda receptor antagonist produces dissociative hallucinogenic states somewhat similar ketamine may produce distortions visual field feelings dissociation distorted bodily perception excitement loss sense time users report stimulantlike euphoria particularly response music dextromethorphan usually provides recreational effects nonlinear fashion experienced significantly varied stages stages commonly referred plateaus plateaus numbered one four first mildest effects fourth intense plateau said come different related effects first plateau said induce music euphoria mild stimulation likened mdma second plateau likened state moderate amounts alcohol cannabis time featuring euphoria sedation minor hallucinations third plateau induces significant dissociative state often cause anxiety users reaching fourth plateau said cause extreme sedation significant hallucinatory state well complete dissociation reality teenagers tend higher likelihood use dextromethorphanrelated drugs easier access easier way cope psychiatric combination drug dextromethorphanquinidine traditionally used treat pseudobulbar affect investigation treatment variety neurological neuropsychiatric conditions including agitation associated alzheimers disease among randomized clinical trial found dextromethorphan may reduce overall discomfort duration withdrawal symptoms associated opioid use disorder combined clonidine dextromethorphan reduced overall time needed withdrawal symptoms peak hours reducing severity symptoms compared clonidine media related dextromethorphan wikimedia commons httpsenwikipediaorgwikidextromethorphan